Matches in Wikidata for { <http://www.wikidata.org/entity/Q66079946> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- Q66079946 description "assaig clínic" @default.
- Q66079946 description "clinical trial" @default.
- Q66079946 description "clinical trial" @default.
- Q66079946 description "clinical trial" @default.
- Q66079946 description "clinical trial" @default.
- Q66079946 description "ensaio clínico" @default.
- Q66079946 description "ensayo clínico" @default.
- Q66079946 description "ensayu clínicu" @default.
- Q66079946 description "essai clinique" @default.
- Q66079946 description "klinisch onderzoek" @default.
- Q66079946 description "клінічне випробування" @default.
- Q66079946 name "Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use" @default.
- Q66079946 name "Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use" @default.
- Q66079946 type Item @default.
- Q66079946 label "Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use" @default.
- Q66079946 label "Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use" @default.
- Q66079946 prefLabel "Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use" @default.
- Q66079946 prefLabel "Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use" @default.
- Q66079946 P1050 Q66079946-8279A1CA-9A6E-4AE1-8DCB-2EA5136A8D10 @default.
- Q66079946 P1050 Q66079946-CBA87621-1E47-44E2-AA46-9B3F4A368BA9 @default.
- Q66079946 P1050 Q66079946-D004931D-2AFE-4B93-B86C-F7D38A49A803 @default.
- Q66079946 P1132 Q66079946-6CF57F90-1796-4695-8B01-89A86D67DFE1 @default.
- Q66079946 P1476 Q66079946-CED6CE12-95AE-4670-B4A9-1AD2E6073785 @default.
- Q66079946 P17 Q66079946-67178EEC-FA74-45C0-849E-02CB63EDF38C @default.
- Q66079946 P17 Q66079946-83606DCA-093D-437A-A698-B103AD3E0583 @default.
- Q66079946 P2899 Q66079946-CC681D80-512A-4D5C-8418-90434CE5862F @default.
- Q66079946 P3098 Q66079946-1F1084CA-E079-4024-9AE7-92330A1F149E @default.
- Q66079946 P31 Q66079946-A8D4B3DB-A770-4B19-AC95-C52736987696 @default.
- Q66079946 P4135 Q66079946-260CB484-4CEC-47F3-BC69-F80CD1515F99 @default.
- Q66079946 P4844 Q66079946-65E9F416-43D0-4588-81AD-F09DF4790AF5 @default.
- Q66079946 P4844 Q66079946-72EB1F78-C4C5-4602-B96E-3E82441722C9 @default.
- Q66079946 P580 Q66079946-BA16857C-711B-4B9B-A546-CD409F99B222 @default.
- Q66079946 P582 Q66079946-DD680076-6364-424C-A79E-C2D66A58C045 @default.
- Q66079946 P6099 Q66079946-B57CB132-1BAC-4B17-93B3-8ADCEF25345A @default.
- Q66079946 P6153 Q66079946-1FFC1D81-1402-4F11-B2E0-F0D90E7D90CA @default.
- Q66079946 P6153 Q66079946-5B6FE5CD-75A7-4CBE-B22C-B970C6CC7952 @default.
- Q66079946 P6153 Q66079946-5BFE73E7-F81F-4339-8D4C-82BDC1DFC3AB @default.
- Q66079946 P6153 Q66079946-9652B45D-3611-4939-AD9C-9E03262FF2D5 @default.
- Q66079946 P6153 Q66079946-A098D37D-54BF-4D24-9C07-1A48A1D475F5 @default.
- Q66079946 P6153 Q66079946-CCAE56EE-4C40-45EA-B0FF-702557B17541 @default.
- Q66079946 P6153 Q66079946-F8C51E2A-3E02-4577-8798-3BFC7ECF6E26 @default.
- Q66079946 P8363 Q66079946-8B68CF34-E393-4E11-AC34-081EC684C089 @default.
- Q66079946 P1050 Q179630 @default.
- Q66079946 P1050 Q40878 @default.
- Q66079946 P1050 Q838966 @default.
- Q66079946 P1132 "+346" @default.
- Q66079946 P1476 "A Phase 4 Multicenter, Multinational, Prospective, Randomized, Placebo-Controlled, Double-Blinded Parallel Group Study to Assess Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D) in Patients Who Report Inadequate Control of IBS-D Symptoms With Prior Loperamide Use (RELIEF)" @default.
- Q66079946 P17 Q16 @default.
- Q66079946 P17 Q30 @default.
- Q66079946 P2899 "+18" @default.
- Q66079946 P3098 "NCT02959983" @default.
- Q66079946 P31 Q30612 @default.
- Q66079946 P4135 "+80" @default.
- Q66079946 P4844 Q20539232 @default.
- Q66079946 P4844 Q423751 @default.
- Q66079946 P580 "2016-10-25T00:00:00Z" @default.
- Q66079946 P582 "2018-01-22T00:00:00Z" @default.
- Q66079946 P6099 Q42825046 @default.
- Q66079946 P6153 Q1067471 @default.
- Q66079946 P6153 Q30269691 @default.
- Q66079946 P6153 Q30269699 @default.
- Q66079946 P6153 Q30269704 @default.
- Q66079946 P6153 Q30270068 @default.
- Q66079946 P6153 Q30270367 @default.
- Q66079946 P6153 Q30298472 @default.
- Q66079946 P8363 Q78089383 @default.